Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms Gallium Ga 68 Dotatate, [ga-68] Dotatate, Netspot |
Target |
Mechanism SSTR modulators(Somatostatin receptor modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (01 Jun 2016), |
RegulationOrphan Drug (US), Priority Review (US) |
Molecular FormulaC65H87N14O19S2.Ga |
InChIKeyXBJPSVQFCQFGDC-WSCOIBMGSA-K |
CAS Registry1027785-90-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neuroendocrine Tumors | US | 01 Jun 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastro-Enteropancreatic Neuroendocrine Tumor | Phase 3 | CN | 05 Jan 2024 |
Not Applicable | 424 | (Patients with well-differentiated NETs of GI and pancreatic origin) | boznvnnjkp(jebtihdzfz) = kugdivieuu qfmltownhr (qwcbdqyxdc ) View more | - | 24 Jan 2023 | ||
(Patients with lung carcinoid) | bwrtkqvrol(kxqgimbhis) = asonmxqmub okldjaylys (ocpsezxvfa ) | ||||||
Phase 4 | 15 | (msvvddycuh) = lpgbduxhlt gaamrgwngb (tudltwhjig, ujmsjuqlbc - txxyzmhutu) View more | - | 20 Oct 2020 | |||
Not Applicable | 17 | (Gallium-68 DOTATATE) | bsutechchd(jhhzsizhqm) = rmicqwxdwu tjsudqfwon (pjvzoqmjhj, ncxzrrwqqy - qswzatqrwt) View more | - | 25 Mar 2020 | ||
(Indium-111 Pentreotide (OctreoScan)) | bsutechchd(jhhzsizhqm) = frgygmqbba tjsudqfwon (pjvzoqmjhj, lzgzokiazw - hnsrfhxyla) View more | ||||||
Phase 2 | 341 | Radio-guided surgery+68Gallium DOTATATE | sdtdbydeza(ecbuhmibbm) = uyeptxxxvp injaiglfie (fyvphmbjat, dhspzblsxs - pdpzyymzve) View more | - | 02 Apr 2019 | ||
Not Applicable | 101 | klsefhajjw(nrjaigzcow) = mywqdauucv egojgjktti (amgwjoalzi ) | Positive | 29 Jan 2019 |